SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Adia Med Reports No Serious Adverse Events in First Pediatric Autism Study Cohort

Adia Med reported no serious adverse events in either study arm in the first cohort. Enrollment and participant follow-up continue.

ADIA

Related stories